Soligenix, inc. (SNGX)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Assets
Current assets:
Cash and cash equivalents

7,203

5,420

6,551

6,986

7,200

8,983

11,720

4,244

6,368

7,809

4,999

5,813

7,143

8,772

5,655

3,183

4,260

4,921

4,033

4,035

5,012

5,525

4,209

5,041

5,606

5,856

6,582

8,127

2,612

3,356

3,698

4,431

5,321

5,996

7,218

4,156

7,451

Contracts and grants receivable

841

1,018

869

1,675

1,105

1,201

998

1,530

826

926

634

714

993

1,206

1,697

1,805

1,023

1,985

1,864

733

345

794

1,338

465

694

867

161

190

656

339

238

239

324

362

297

336

120

Research and development incentives receivable

415

444

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax receivable

836

-

-

-

610

-

0

0

0

416

-

-

-

0

-

-

-

-

-

-

-

-

0

0

0

750

-

-

-

0

-

-

0

574

-

-

251

Other receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

Other receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

4

-

Prepaid expenses and other current assets

271

609

589

149

211

157

420

122

159

263

120

129

137

134

225

229

89

244

158

243

131

172

205

63

97

135

198

194

170

140

209

249

144

195

154

91

187

Total current assets

9,569

7,493

8,010

8,811

9,127

10,342

13,139

5,898

7,354

9,415

5,754

6,657

8,274

10,113

7,578

5,218

5,373

7,151

6,056

5,012

5,489

6,492

5,753

5,569

6,398

7,609

6,942

8,512

3,439

3,836

4,146

4,920

5,789

7,129

7,670

4,589

8,011

Security deposit

22

22

22

22

22

22

22

22

22

22

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Office furniture and equipment, net

38

36

9

12

16

19

25

30

34

37

16

20

23

26

33

39

44

47

54

52

57

51

53

53

36

23

18

16

11

12

14

16

13

15

16

17

20

Deferred issuance costs

21

39

60

74

59

59

47

140

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets, net

12

19

26

33

40

46

53

60

67

73

80

95

111

126

142

157

173

188

244

300

355

409

466

522

577

632

688

745

800

855

911

974

1,023

1,079

1,227

1,246

1,235

Right-of-use lease assets

90

125

159

192

224

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development incentives receivable

56

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

34

38

42

46

30

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total assets

9,847

7,775

8,331

9,192

9,521

10,491

13,289

6,152

7,478

9,549

5,852

6,773

8,409

10,267

7,753

5,416

5,591

7,387

6,355

5,366

5,902

6,954

6,272

6,145

7,012

8,265

7,650

9,273

4,251

4,705

5,073

5,911

6,826

8,223

8,915

5,852

9,268

Liabilities and shareholders' equity
Current liabilities:
Accounts payable

2,870

2,735

2,257

2,451

1,582

2,126

1,713

1,686

1,753

1,753

1,477

1,611

1,346

1,708

3,120

4,177

4,632

2,869

4,347

2,636

2,543

3,003

3,059

1,965

1,552

1,520

1,214

1,364

1,651

1,124

1,023

1,219

1,230

1,303

1,371

1,373

1,674

Deferred revenue

-

-

34

69

104

-

259

56

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

3,326

3,157

3,161

2,791

2,296

1,790

1,984

1,729

1,606

1,143

1,091

1,482

1,073

806

1,075

-

-

1,510

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

298

292

286

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,324

1,148

1,673

2,434

2,139

6,201

5,152

3,789

7,429

8,774

9,521

8,281

9,975

5,177

-

0

-

-

-

-

-

-

-

Accrued compensation

43

298

38

50

30

294

63

56

48

333

138

57

172

355

62

56

35

298

48

48

32

315

59

70

45

233

55

276

24

29

28

71

116

129

41

49

236

Lease liabilities - current

88

121

141

136

132

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

6,328

6,312

5,634

5,500

4,147

4,211

4,020

3,529

3,408

3,229

2,707

3,151

2,592

2,869

5,583

5,382

6,641

7,405

6,821

8,886

7,728

7,108

10,548

10,810

11,119

10,035

11,246

6,819

1,675

1,153

1,051

1,291

1,346

1,432

1,413

1,423

1,910

Non-current liabilities:
Lease liabilities, net of current

4

6

19

56

92

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

6,333

6,318

5,654

5,556

4,239

4,211

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

-

0

-

0

-

0

0

0

0

0

0

0

-

-

-

Shareholders' equity:
Preferred stock, 350,000 shares authorized; none issued or outstanding

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $.001 par value; 50,000,000 shares authorized; 25,778,431 shares and 1,753,124 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

25

21

20

18

18

17

17

8

8

8

5

5

5

5

3

3

31

3

27

26

25

2

22

20

19

19

19

19

11

11

11

11

11

11

220

218

10

Additional paid-in capital

186,624

177,006

175,326

173,557

173,076

172,436

172,317

163,817

163,708

163,581

158,269

157,784

157,667

157,514

151,959

148,150

146,945

146,856

144,325

144,047

141,764

138,890

136,671

131,935

131,544

130,549

129,717

129,208

125,932

125,820

125,305

125,145

125,024

124,897

124,465

123,601

123,085

Accumulated other comprehensive loss

-28

-45

-14

-7

-3

-3

-1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated deficit

-183,106

-175,525

-172,653

-169,933

-167,809

-166,170

-163,065

-161,203

-159,647

-157,270

-155,131

-154,167

-151,856

-150,122

-149,793

-148,119

-148,027

-146,877

-144,819

-147,593

-143,615

-139,046

-140,969

-136,619

-135,671

-132,339

-133,332

-126,772

-123,367

-122,280

-121,294

-120,536

-119,556

-118,117

-117,185

-119,390

-115,738

Total shareholders' equity

3,514

1,457

2,677

3,636

5,281

6,280

9,268

2,622

4,070

6,319

3,144

3,621

5,816

7,397

2,170

33

-1,050

-18

-466

-3,519

-1,825

-153

-4,275

-4,664

-4,106

-1,769

-3,595

2,454

2,576

3,551

-

-

-

6,791

-

-

-

Total shareholders equity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,021

4,620

5,479

-

7,501

4,429

7,357

Total liabilities and shareholders' equity

9,847

7,775

8,331

9,192

9,521

10,491

13,289

6,152

7,478

9,549

5,852

6,773

8,409

10,267

7,753

5,416

5,591

7,387

6,355

5,366

5,902

6,954

6,272

6,145

7,012

8,265

7,650

9,273

4,251

4,705

5,073

5,911

6,826

8,223

8,915

5,852

9,268